The NICD publishes a number of publications on a weekly, monthly and quarterly basis that cover a range of topical themes on communicable diseases and comprise of the below publications:
The Communicable diseases communiqué is published on a monthly basis for the purpose of providing up-to-date information on communicable diseases in South Africa. Much of the information is preliminary and should not be cited or utilised for publication.
Communiqué is released monthly – to download and view past Communiqué publications, go to Archives.
In This Issue
The Public Health Surveillance Bulletin is a quarterly publication which provides information on surveillance activities, which enables effective monitoring of rates and distribution of diseases, detection of outbreaks, monitoring of interventions, and predicting emerging hazards. The Surveillance Reports are analyses and interpretation of surveillance data, primarily from notifiable medical conditions.
The Invasive Pneumococcal Disease (IPD) cumulative graphs report provides a summary of the total number of IPD cases reported to GERMS-SA to date, and if vaccine or non-vaccine serotypes of Streptococcus pneumoniae were identified. GERMS-SA is a national, active, laboratory-based surveillance system initiated in 2003 and this report is updated on a quarterly basis.
The Weekly and Monthly Respiratory Pathogens Surveillance Report is published weekly and offers information and data about influenza, pneumonia and Respiratory Syncytial virus trends across South Africa. It offers an outlook where data collected is measured on the epidemic threshold to determine a pandemic.
To download and view past reports, go to Archives.
GERMS-SA’s main objective is to provide strategic information regarding trends in the pathogens of public health importance, e.g. vaccine-preventable diseases to measure the impact of vaccines, epidemic-prone diseases to monitor and respond to outbreaks, healthcare-associated bloodstream infections with the trend of antibiotics resistance and the burden of HIV-associated opportunistic infections (OI).